2022
DOI: 10.3390/biomedicines10102398
|View full text |Cite
|
Sign up to set email alerts
|

Latent Tuberculosis: A Promising New Compound to Treat Non-Replicating and Intramacrophagic Mycobacteria

Abstract: As a biologic reservoir of Mycobacterium tuberculosis (M. tb), one-quarter of the world population is infected with the well-known latent tuberculosis (LTBI). About 5–10% of LTBI patients will progress to active disease in the first years after primary infection and, despite using the recommended treatment, 20% can still reactivate the infection. A new LTBI treatment could minimize adverse effects and antibiotic resistance that can occur when the same drug is used to treat the latent and active disease. New hy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…The evolution between TB infection and active TB is multifactorial and the synthesis of ESAT-6 or the induction of alveolar macrophage necrosis are key 4 . About 5–10% of latent TB infection patients will progress to active disease in the first years after primary infection and, despite using the recommended treatment, 20% can still reactivate the infection 5 . Hence, early diagnosis and prevention of latent TB is an important healthcare management strategy to control TB progression.…”
Section: Introductionmentioning
confidence: 99%
“…The evolution between TB infection and active TB is multifactorial and the synthesis of ESAT-6 or the induction of alveolar macrophage necrosis are key 4 . About 5–10% of latent TB infection patients will progress to active disease in the first years after primary infection and, despite using the recommended treatment, 20% can still reactivate the infection 5 . Hence, early diagnosis and prevention of latent TB is an important healthcare management strategy to control TB progression.…”
Section: Introductionmentioning
confidence: 99%